Clinical Trials for WT1-A10 AS01B ASCI

1 Open Trial

Trial TypeProtocol No. &
Open Date
Summary
TreatmentVICCPHI1040
12/21/2010
A Phase I Study to Evaluate the Safety and Clinical Activity of WT1-A10+AS01B Antigen Specific Cancer Immunotherapeutic in Adult Patients with WT1-Positive Acute Myeloid Leukemia in Partial Remission with Incomplete Blood Count Recovery Post-Induction Therapy

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.